Researchers trial inhalable gene therapy for cystic fibrosis, offering a potential breakthrough in treating the genetic lung ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis is being tested in human ...

BI 3720931 is a first-in-class, inhaled lentiviral vector-based gene therapy that could potentially address unmet needs by inserting a functional copy of the CFTR gene in the DNA of airway epithelial ...

Researchers at Imperial College London are leading human trials for the innovative treatmentAn inhalable medicine with the potential to improve lung ...

The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

In my hands-on testing, I also tried out GoogieHost’s homemade control panel that’s based on cPanel mechanics, and it worked as advertised. Everything is clearly laid out, and although design ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations in genetic material delivery.